SEGMENT REPORTING (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Segment Reporting Information [Line Items]
Infusion services net revenue	$ 4,911,591	$ 4,222,656	$ 3,869,036
Other	86,611	79,668	75,699
Total Option Care Health revenue	4,998,202	4,302,324	3,944,735
Income (Expense) [Abstract]
Cost of net revenues - drugs	(3,446,735)	(2,812,531)	(2,562,494)
Salaries, benefits, and other employee expense	(787,922)	(760,499)	(709,916)
Other segment items	(380,803)	(355,498)	(371,529)
Depreciation and amortization expense	(60,909)	(59,201)	(60,565)
Interest expense, net	(49,029)	(51,248)	(53,806)
Equity in earnings of joint ventures	5,964	5,530	5,125
Other, net	4,831	89,865	14,218
INCOME TAX EXPENSE	(71,776)	(91,652)	(55,212)
NET INCOME	$ 211,823	$ 267,090	$ 150,556
Largest Payer | Revenue from Contract with Customer Benchmark | Customer Concentration Risk
Income (Expense) [Abstract]
Concentration risk	15.00%	14.00%	14.00%